Work

Phase II study of 250 mg gefitinib in advanced squamous cell carcinoma of the head and neck (SCCHN)

Year: 2004

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2004.22.14_suppl.5586

Authors: M. A. Kane, E. Cohen, M. List, B. Mehrotra, D. Gustin, A. Mauer, D. Cella, E. Vokes

Institutions: Northwestern University, University of Chicago, University of Colorado Denver

Language: English

Topic: Head and Neck Cancer Studies

Subfield: Otorhinolaryngology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2596354356

Cites:

Cited by: 24

Related to: 10